Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge rates TNON Bullish with a Setup Score of 35, net conviction 29, actionability 42. How the Setup Score works →
| Total Setup Score | 35 |
|---|---|
| Directional Bias | Bullish |
| Net Conviction | 29 |
| Actionability | 42 (in range) |
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. Read full Trend Edge analysis →
| Current Price | $2.98 |
|---|---|
| Market Cap | $9.2M |
| Float | 621K |
| Shares Outstanding | 2.7M |
| Price/Sales (TTM) | 1.74 |
| vs. Analyst Target | +1389.1% to analyst PT |
| Profit Margin | -257.85% |
| Operating Margin (TTM) | -262.24% |
| Revenue (TTM) | $5.3M |
| Dividend Rate | None |
| Analyst Target Price | $44.38 (2 analysts) |
| Year | Revenue | Net Income | Gross Profit | EBITDA |
|---|---|---|---|---|
| 2020 | $43,820 | -$585,178 | $25,563 | -$537,519 |
| 2021 | $160,000 | -$7.0M | $105,000 | -$6.3M |
| 2022 | $691,000 | -$18.9M | -$641,000 | -$18.3M |
| 2023 | $2.9M | -$15.6M | $1.2M | -$15.1M |
| 2024 | $3.3M | -$13.7M | $1.7M | -$13.0M |
| 2025 | $3.9M | -$12.6M | $2.4M | -$12.0M |
| Quarter | Revenue | Net Income |
|---|---|---|
| Sep 2025 | $1.2M | -$3.3M |
| Dec 2025 | $1.5M | -$2.8M |
| Mar 2026 | $1.4M | -$3.5M |
| Jun 2026 | $1.3M | -$4.0M |
| Insider Ownership | 5.9% |
|---|---|
| Institutional Ownership | 4.5% |
| Short Float | 21.0% |
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
| Timeframe | SMA | Value | Trend Context |
|---|---|---|---|
| Weekly | 10-Week SMA | $4.39 | Near-term / short-term trend |
| Weekly | 40-Week SMA | $3.36 | Medium-term trend |
| Weekly | 80-Week SMA | $2.25 | Cyclical trend (business cycle) |
| Weekly | 200-Week SMA | $22.76 | Secular trend (multi-year) |
| Monthly | 10-Month SMA | $2.28 | Near-term monthly trend |
| Monthly | 20-Month SMA | $1.74 | Medium-term monthly trend |
| Monthly | 40-Month SMA | $5.02 | Secular monthly trend |
Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
| Price Level | Type | Volume Ratio | Age |
|---|---|---|---|
| $6.30 | resistance | 1.47x | 1 months ago |
| Timeframe | Avg Return | Median | Win Rate | Best | Worst |
|---|---|---|---|---|---|
| Gap | -1.36% | -0.17% | 38.89% | 11.72% | -18.56% |
| 1 Day | -3.94% | -2.60% | 22.22% | 14.36% | -22.76% |
| 1 Week | -8.07% | -10.20% | 16.67% | 25.35% | -35.67% |
| 2 Weeks | -16.38% | -13.46% | 0.00% | -0.80% | -37.93% |
| 1 Month | -18.88% | -17.98% | 11.11% | 64.74% | -60.19% |
Next earnings: November 12, 2026 (30 days away)
Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).
| Day | Avg Return | Win Rate | Samples |
|---|---|---|---|
| Monday | 37.81% | 34.3% | 207 |
| Tuesday | 0.35% | 39.0% | 231 |
| Wednesday | -0.22% | 38.4% | 229 |
| Thursday | 12.72% | 43.3% | 224 |
| Friday | 14.39% | 37.2% | 226 |
Institutional holder breakdown coming soon.
Total institutional ownership: 4.5%
Total insider ownership: 5.9%
Founder-led management: Richard Ferrari (Founder & Executive Chairman), Richard Ginn (Founder, Chief Technology Officer & Chief Operating Officer)
| Total Filings | 8 |
|---|---|
| Net Value | +N/A |
| Net Shares Change | 133,423 |
| % of Float | 21.5% |
| C-Suite Filings | 3 |
| Clusters Detected | 1 |
| Name | Title | Net Value | Filings | Activity |
|---|---|---|---|---|
| HRT FINANCIAL LP | -$105,442.075 | 5 | 4 buy, 5 sell | |
| Grawey Nathaniel A. | Chief Commercial Officer | +N/A | 1 | 1 buy |
| FOSTER STEVEN M | CEO and President | +N/A | 1 | 1 buy |
| Geist Wyatt D. | Chief Innovation Officer | +N/A | 1 | 1 buy |
| Period | Filings | Insiders | Net Value | Seniority |
|---|---|---|---|---|
| 2025-11-18 – 2025-11-18 | 3 | 3 | +N/A | 3 C-suite |
| Date | Insider | Title | Net Value | Price After |
|---|---|---|---|---|
| 2026-09-11 | HRT FINANCIAL LP | -$155,655.564 | Transaction at $3.91, now -23.8% | |
| 2026-09-03 | HRT FINANCIAL LP | +$6,141.8 | Transaction at $4.55, now -34.5% | |
| 2026-09-08 | HRT FINANCIAL LP | +$1,026.64 | Transaction at $3.84, now -22.4% | |
| 2026-09-01 | HRT FINANCIAL LP | +$45,123.288 | Transaction at $6.25, now -52.3% | |
| 2025-11-18 | Grawey Nathaniel A. | Chief Commercial Officer | +N/A | N/A |
| 2025-11-18 | FOSTER STEVEN M | CEO and President | +N/A | N/A |
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Tenon Medical Inc (TNON) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.
Get the full AI Consult analysis for TNON on Trend Edge →